At Circular Smart, we are driven by a team of seasoned commercial leaders, business development strategists, and industry-leading MedTech professionals who bring decades of experience in medical technology, healthcare innovation, and global market expansion. Our leadership team has successfully navigated complex regulatory landscapes, forged high-impact partnerships, and scaled transformative healthcare solutions across international markets.
Complementing our commercial and industry expertise, our AI and IoT innovators and technologists are at the forefront of integrating cutting-edge artificial intelligence, cloud-based diagnostics, and IoT-enabled medical solutions. Together, we are redefining the future of precision diagnostics and connected healthcare, delivering scalable, AI-powered solutions that enhance efficiency, accuracy, and accessibility for medical professionals and patients worldwide.
At Circular Smart Limited owners of IOMedTech, we are backed by a combination of forward-thinking private investors and strategic European national grant programs, enabling us to drive groundbreaking innovation in AI-powered precision diagnostics. Our investors are experienced visionaries who recognize the transformative potential of next-generation MedTech solutions and share our mission to revolutionize global healthcare.
We take a smart, strategic, and diligent approach to managing investor capital, ensuring that every euro is allocated effectively to fuel scalable growth, regulatory milestones, and commercialization success. Our commitment extends beyond just delivering cutting-edge technology—we aim to create a lasting impact on human health while providing an exceptional return on investment. With a clear roadmap for expansion and a strong exit strategy, we position our investors to benefit from both financial success and meaningful contributions to the future of medical diagnostics.
At CircularSmart, our strategy is built on forging long-lasting, profitable, and impactful partnerships with Lateral Flow Test (LFT) manufacturers, hospital clinics, GP offices, and national health programs worldwide. We believe that by collaborating with key stakeholders across the healthcare ecosystem, we can drive the widespread adoption of AI-powered rapid diagnostics, revolutionizing disease detection and patient care.
Our approach is centered on scalability, integration, and accessibility—ensuring that our Look SPOT technology seamlessly enhances existing healthcare infrastructures, providing a faster, more accurate, and cost-effective way to diagnose a broad range of diseases. By working closely with manufacturers, we empower them with cutting-edge AI and IoT advancements, while hospitals, clinics, and GP offices benefit from real-time, automated testing that improves efficiency and clinical outcomes.
With a strong commitment to global healthcare transformation, we actively engage with national health programs to support their public health objectives, enabling early disease detection, efficient outbreak management, and improved patient pathways. Through these strategic alliances, we ensure sustained growth, market expansion, and high-value impact—delivering not just medical innovation, but measurable advancements in global health and strong financial returns for our stakeholders.
